A phase 2, open label, multicenter, single arm study of...

Contemporary Clinical Trials Communications 2020 / 12 Vol. 20

A phase 2, open label, multicenter, single arm study of tocilizumab on the efficacy and tolerability of tocilizumab in the treatment of patients with COVID-19 pneumonia (TOCIVID-19 trial): Statistical analysis plan

Chiodini, Paolo, Arenare, Laura, Piccirillo, Maria Carmela, Perrone, Francesco, Gallo, Ciro
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
20
Journal:
Contemporary Clinical Trials Communications
DOI:
10.1016/j.conctc.2020.100665
Date:
December, 2020
File:
PDF, 1.63 MB
2020
Conversion to is in progress
Conversion to is failed